LP30486-2
Arbekacin
Active
Description
Arbekacin (INN) is a semisynthetic aminoglycoside antibiotic. It is primarily used for the treatment of infections caused by multi-resistant bacteria including methicillin-resistant Staphylococcus aureus (MRSA).[1][2] Arbekacin was originally synthesized from dibekacin in 1973. It has been registered and marketed in Japan since 1990 under the trade name Habekacin.[3] Arbekacin is no longer covered by patent and generic versions of the drug are also available under such trade names as Decontasin and Blubatosine. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Arbekacin
Basic Part Properties
- Part Display Name
- Arbekacin
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2002-08-06
- Construct for LOINC Short Name
- Arbekacin
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP30486-2
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 黄花高 Synonyms: Arbekacin; |
| fr-CA | French (Canada) | Arbékacine |
| et-EE | Estonian (Estonia) | Arbekatsiin |
| es-ES | Spanish (Spain) | Arbekacina |
| it-IT | Italian (Italy) | Arbecacina |
| tr-TR | Turkish (Turkey) | Arbekasin |
| ru-RU | Russian (Russian Federation) | Арбекацин |
| nl-NL | Dutch (Netherlands) | arbekacine |
| fr-BE | French (Belgium) | Arbékacine |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright